Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States

被引:45
作者
Sullivan, PS
Do, AN
Ellenberger, D
Pau, CP
Paul, S
Robbins, K
Kalish, M
Storck, C
Schable, CA
Wise, H
Tetteh, C
Jones, JL
McFarland, J
Yang, CF
Lal, RB
Ward, JW
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div HIV STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[3] New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA
[4] New York City Dept Hlth, New York, NY 10013 USA
关键词
D O I
10.1086/315254
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A population-based surveillance registry was used to identify human immunodeficiency virus (HIV)-infected persons in the United States at increased risk for group O and group N infections (those born in or near African countries where group O infection has been reported). Of 155 eligible subjects, 37 gave samples. By phylogenetic and serologic analysis, 32 were infected with group M (16 with subtype A, 5 with B, 7 with C, and 1 each with subtypes D, F2, G, and recombinant A/J) and 2 with group O but none with group N virus. For 3, samples could not be typed by serology or amplified by polymerase chain reaction using group M-, O-, or N-specific primers. In the United States, group O HIV infection is uncommon; no case of group N infection was found. African-born persons may have HIV strains typical of their birth country. Ongoing subtype surveillance may allow early identification of novel or emerging HIV strains.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 40 条
[1]   Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D [J].
Alaeus, A ;
Lidman, K ;
Björkman, A ;
Giesecke, J ;
Albert, J .
AIDS, 1999, 13 (08) :901-907
[2]   Subtype-specific problems with quantification of plasma HIV-1 RNA [J].
Alaeus, A ;
Lidman, K ;
Sonnerborg, A ;
Albert, J .
AIDS, 1997, 11 (07) :859-865
[3]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[4]   Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions [J].
Apetrei, C ;
LoussertAjaka, I ;
Descamps, D ;
Damond, F ;
Saragosti, S ;
BrunVezinet, F ;
Simon, F .
AIDS, 1996, 10 (14) :F57-F60
[5]  
BEATRICE ST, 1998, 12 WORLD AIDS C GEN
[6]   Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda [J].
Brennan, CA ;
Lund, JK ;
Golden, A ;
Yamaguchi, J ;
Vallari, AS ;
Phillips, JF ;
Kataaha, PK ;
Jackson, JB ;
Devare, SG .
AIDS, 1997, 11 (15) :1823-1832
[7]   DETECTION OF DIVERSE HIV-1 GENETIC SUBTYPES IN THE USA [J].
BRODINE, SK ;
MASCOLA, JR ;
WEISS, PJ ;
ITO, SI ;
PORTER, KR ;
ARTENSTEIN, AW ;
GARLAND, FC ;
MCCUTCHAN, FE ;
BURKE, DS .
LANCET, 1995, 346 (8984) :1198-1199
[8]   INVESTIGATIONS OF AIDS PATIENTS WITH NO PREVIOUSLY IDENTIFIED RISK-FACTORS [J].
CASTRO, KG ;
LIFSON, AR ;
WHITE, CR ;
BUSH, TJ ;
CHAMBERLAND, ME ;
LEKATSAS, AM ;
JAFFE, HW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (09) :1338-1342
[9]  
Centers for Disease Control and Prevention, 1997, HIV AIDS SURVEILLANC, V9, P1
[10]   Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes, and assay evaluation [J].
Cheingsong-Popov, R ;
Osmanov, S ;
Pau, CP ;
Schochetman, G ;
Barin, F ;
Holmes, H ;
Francis, G ;
Ruppach, H ;
Dietrich, U ;
Lister, S ;
Weber, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (04) :311-318